Must Asset Management Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Must Asset Management Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$214,884
-51.2%
6,198
-47.4%
0.59%
-45.8%
Q1 2023$440,034
+73.9%
11,794
+84.6%
1.09%
+567.1%
Q3 2021$253,000
-13.4%
6,3880.0%0.16%
-20.4%
Q2 2021$292,000
-82.4%
6,388
-84.2%
0.21%
-84.1%
Q1 2021$1,658,000
+13.6%
40,356
+17.8%
1.30%
+24.6%
Q4 2020$1,459,00034,2501.04%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders